Lithium can be toxic if not used properly. Further, the research is still in the early stages and it is unlikely that a ...

TSPO levels rise early in Alzheimer’s and persist throughout disease. Targeting this biomarker could open new treatment options. TSPO, a major marker of brain inflammation, may offer a way to detect ...

While our understanding of Alzheimer’s disease is far from complete, the latest therapies, and others in more than 100 ...

One of neurologist Anelyssa D’Abreu’s least favorite tasks is giving her patients a dreaded diagnosis: early-stage ...

Plasma p-tau181 is a promising biomarker that can help identify Alzheimer's disease pathology and distinguish those who are at risk for conversion to dementia.

More than seven million Americans suffer from Alzheimer’s disease, but experts are working hard to make sure fewer people suffer in the future. One local Alzheimer’s expert, Dr. Hamid Okhravi of ...

New Alzheimer’s drugs known as anti-amyloid therapies may slow disease progression—but they also carry serious risks, ...

EmblemHealth, a health insurer with locations on Long Island, is partnering with physician-researcher Dr. Dean Ornish and chef-led meal service CookUnity to provide medically tailored meals as part of ...